Madrigal Pharmaceuticals Overview
Madrigal Pharmaceuticals Target Price
Analysts' 12-month price predictions for MDGL.
Get informed when a big investor buys or sells
+ FollowShare Price
$553.48
Average Target Price
$619.50
11.9% upside
11.9% upside4 analysts in the last 4 months
High: $709 | Low: $542
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-11 | Morgan Stanley | $542 |  2.1% downside |  |
| 2026-05-13 | Truist Financial | $709 | 28.1% upside | |
| 2026-05-07 | Evercore ISI | $649 | 17.3% upside | |
| 2026-05-07 | Canaccord Genuity | $578 | 4.4% upside | |
| 2026-01-27 | Barclays | $964 | 74.2% upside | |
| 2026-01-14 | Goldman SachsAndrea Tan | $571 | 3.2% upside | |
| 2026-01-06 | Wolfe ResearchAndy Chen | $579 | 4.6% upside | |
| 2025-12-19 | UBS | $900 | 62.6% upside | |
| 2025-12-19 | Piper SandlerYasmeen Rahimi | $900 | 62.6% upside | |
| 2025-11-21 | H.C. Wainwright | $620 | 12% upside | |
| 2025-11-20 | OppenheimerJay Olson | $650 | 17.4% upside | |
| 2025-11-19 | Truist Financial | $640 | 15.6% upside | |
| 2025-11-05 | JMP Securities | $527 | 4.8% downside | |
| 2025-10-15 | Piper Sandler | $540 | 2.4% downside | |
| 2025-10-14 | Truist Financial | $580 | 4.8% upside | |
| 2025-10-10 | OppenheimerJay Olson | $590 | 6.6% upside | |
| 2025-05-02 | Canaccord GenuityEdward Nash | $420 | 24.1% downside | |
| 2024-05-29 | Piper SandlerYasmeen Rahimi | $336 | 39.3% downside | |
| 2024-05-09 | H.C. WainwrightEd Acre | $390 | 29.5% downside | |
| 2024-03-19 | Evercore ISILiisa Bayko | $405 | 26.8% downside | |
| 2024-03-15 | UBSEliana Merle | $410 | 25.9% downside | |
| 2024-03-15 | JefferiesAkash Tewari | $400 | 27.7% downside | |
| 2024-03-15 | H.C. WainwrightEd Acre | $425 | 23.2% downside | |
| 2024-03-15 | JMP SecuritiesJonathan Wolleben | $397 | 28.3% downside | |
| 2024-03-15 | B.Riley FinancialMayank Mamtani | $270 | 51.2% downside | |
| 2023-01-05 | JMP Securities | $390 | 29.5% downside | |
| 2022-12-21 | UBS | $337 | 39.1% downside | |
| 2022-12-20 | H.C. Wainwright | $225 | 59.3% downside | |
| 2022-12-20 | Oppenheimer | $250 | 54.8% downside | |
| 2022-12-20 | Goldman Sachs | $375 | 32.2% downside | |
| 2022-12-20 | JMP Securities | $312 | 43.6% downside | |
| 2022-12-20 | Leerink Partners | $315 | 43.1% downside | |
| 2021-08-06 | BMO CapitalMatthew Luchini | $111 | 79.9% downside | |
| 2021-05-20 | Goldman SachsAndrea Tan | $195 | 64.8% downside | |
| 2021-05-06 | Wells FargoDerek Archila | $130 | 76.5% downside | |